Ben Cole
@belfastheartdoc.bsky.social
Cardiologist interested in all things imaging. #cardiosky
Reposted by Ben Cole
In a meta-analysis of 17,801 patients with myocardial infarction and preserved LVEF (≥50%), beta-blockers did not reduce death, MI, or heart failure over a median 3.6 years of follow-up. Full results: nej.md/43U5Ppo
#AHA25
#AHA25
November 9, 2025 at 4:14 PM
In a meta-analysis of 17,801 patients with myocardial infarction and preserved LVEF (≥50%), beta-blockers did not reduce death, MI, or heart failure over a median 3.6 years of follow-up. Full results: nej.md/43U5Ppo
#AHA25
#AHA25
Reposted by Ben Cole
AI-ECG Finds STEMI Faster, Cuts False-Positive Cath Lab Activations
AI-ECG Finds STEMI Faster, Cuts False-Positive Cath Lab Activations
AI-ECG Finds STEMI Faster, Cuts False-Positive Cath Lab Activations
ccox@crf.org
Wed, 10/29/2025 - 13:57
Todd Neale
Physicians will remain in the loop, but AI can “turbocharge and augment our abilities,” an emergency medicine physician says.
www.tctmd.com
October 31, 2025 at 1:02 PM
AI-ECG Finds STEMI Faster, Cuts False-Positive Cath Lab Activations
Reposted by Ben Cole
Its back! Ten current papers for the curious cardiologist, including BP targets in T2DM, spiro post MI, left atrial appendage occlusion, coronary sinus reducer for angina, device detected AF & tirzepatide in HFpEF #CardioSky
1/11
1/11
November 18, 2024 at 10:24 PM
Its back! Ten current papers for the curious cardiologist, including BP targets in T2DM, spiro post MI, left atrial appendage occlusion, coronary sinus reducer for angina, device detected AF & tirzepatide in HFpEF #CardioSky
1/11
1/11
Reposted by Ben Cole
7/
So, what to make of a trial with 50% lower events than expected (sum total of 85 events over 3y in a trial enrolling 1600 patients), lots of missing data, & biased choice of safety outcome?
Enthusiasts of LAAC will celebrate 'win', but should clinicians & payers join in?
So, what to make of a trial with 50% lower events than expected (sum total of 85 events over 3y in a trial enrolling 1600 patients), lots of missing data, & biased choice of safety outcome?
Enthusiasts of LAAC will celebrate 'win', but should clinicians & payers join in?
November 16, 2024 at 8:08 PM
7/
So, what to make of a trial with 50% lower events than expected (sum total of 85 events over 3y in a trial enrolling 1600 patients), lots of missing data, & biased choice of safety outcome?
Enthusiasts of LAAC will celebrate 'win', but should clinicians & payers join in?
So, what to make of a trial with 50% lower events than expected (sum total of 85 events over 3y in a trial enrolling 1600 patients), lots of missing data, & biased choice of safety outcome?
Enthusiasts of LAAC will celebrate 'win', but should clinicians & payers join in?
Reposted by Ben Cole
In 2019, we wrote a paper showing that patients with left ventricular thrombus have a long-term risk of embolism, extending to at least 8 years.
We were puzzled by the finding…
#CardioSky
www.ahajournals.org/doi/10.1161/...
We were puzzled by the finding…
#CardioSky
www.ahajournals.org/doi/10.1161/...
November 12, 2024 at 7:34 PM
In 2019, we wrote a paper showing that patients with left ventricular thrombus have a long-term risk of embolism, extending to at least 8 years.
We were puzzled by the finding…
#CardioSky
www.ahajournals.org/doi/10.1161/...
We were puzzled by the finding…
#CardioSky
www.ahajournals.org/doi/10.1161/...